South Africa tour of India 2019
Centre Approves Intranasal Covid Vaccine For Booster.
On Friday, the Centre approved Bharat Biotech‘s needle-free intranasal Covid vaccine for booster dose, said an official source.
Nasal vaccines are approved for adults over the age of 18. Initially, the vaccine will be available in private hospitals for booster doses.
The nasal vaccine would be used as a heterologous booster among the eligible population. Meanwhile, the source expects the intranasal Covid vaccine to be introduced in the Covid-19 vaccination program on Friday.
Cowin App users can access the nasal vaccine from this day forward.
Meanwhile, India on Friday reported 163 fresh Covid-19 cases, along with nine deaths that have also been reported in the country. The number of active coronavirus cases declined to 3,380.
Comments